As of Jun 27
| +0.08 / +7.41%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 3.00, with a high estimate of 10.00 and a low estimate of 2.30. The median estimate represents a +158.62% increase from the last price of 1.16.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.